Subsequently, DSS-induced colitis was used to measure the level of IDO1, GRP78, XBP1, and M1 marker iNOS correlated with disease activity, while 1MT treatment ameliorated DSS-induced colitis by downregulating IDO1-GRP78-XBP1 pathway. This evidence concerns the gene IDO1 and colitis.